News

Zacks Investment Research on MSN4h
AZN Gets CHMP Nod for Imfinzi in Muscle-Invasive Bladder Cancer
AstraZeneca AZN announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) rendered ...
BeiGene gets EU backing for neck and head cancer treatment
BeiGene (NASDAQ:ONC) (OTCPK:BEIGF) announced that an advisory committee of the European Medicines Agency (EMA), endorsed its ...
Healio1h
FDA grants rare pediatric disease designation for Stargardt disease gene therapy
The FDA granted rare pediatric disease designation for OCU410ST, a gene therapy designed to treat ABCA4-associated ...
BeiGene's Tevimbra Gets Positive Opinion from Committee for Medicinal Products for Human Use
BeiGene's Tevimbra gets a highly sought after recommendation.
Medscape4d
Blenrep Gets European Nod to Treat Multiple Myeloma
Adding Blenrep to standard therapy prolonged progression-free survival in patients with relapsed or refractory multiple ...
The Pharma Letter4d
May batch of novel medicines recommended for approval by CHMP
The European Medicines Agency’s (EMA) human medicines committee (CHMP) recommended six novel medicines for approval at its ...
Ocugen's Retina Gene Therapy Drug Gets Rare Disease Designation From FDA
Ocugen's drug to treat retina diseases received a rare pediatric disease designation from U.S. regulators. The biotechnology said Tuesday that the Food and Drug Administration granted the designation ...